Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

NCT00927875 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer

NCT03575793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

NCT00006229 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

NCT04691063 ·Status: UNKNOWN ·Phase: PHASE3

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer

NCT05728619 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

NCT02668393 ·Status: COMPLETED ·Phase: PHASE1

Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)

NCT00411593 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Trial of BMS-986012 in Combination With Platinum and Etoposide

NCT02815592 ·Status: COMPLETED ·Phase: PHASE1

Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide

NCT02250404 ·Status: WITHDRAWN

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer

NCT01837329 ·Status: COMPLETED ·Phase: PHASE1

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

NCT07141771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

NCT02446704 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00453154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

NCT02316327 ·Status: COMPLETED ·Phase: PHASE4

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

NCT05353439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer

NCT01987232 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer

NCT01357395 ·Status: COMPLETED ·Phase: PHASE2

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03184571 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy

NCT06501976 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

BI 2536 Second Line Monotherapy in SCLC

NCT00412880 ·Status: COMPLETED ·Phase: PHASE2

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

NCT02179528 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

NCT05309629 ·Status: COMPLETED ·Phase: PHASE2

A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer

NCT02424617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

NCT00308529 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)

NCT01024062 ·Status: COMPLETED ·Phase: PHASE2